$43.95B
Revenue
$8.06B
Net Income
-78.55%
Gross Margin
-
Op. Margin
$10.96B
Free Cash Flow
| Breakdown | Q3 2025 (Sep 30, 2025) |
Q2 2025 (Jun 30, 2025) |
Q1 2025 (Mar 31, 2025) |
Q4 2024 (Dec 31, 2024) |
Q3 2024 (Sep 30, 2024) |
Q2 2024 (Jun 30, 2024) |
|---|---|---|---|---|---|---|
| Total Revenue | $12.18B | $11.02B | $9.94B | $10.81B | $9.84B | $9.09B |
| Revenue Growth % (YoY) | 23.8% | 21.2% | nan% | nan% | nan% | nan% |
| Cost of Revenue | $15.68B | $13.94B | $12.22B | $36.63B | $6.23B | $5.58B |
| Gross Profit | $-3.50B | $-2.92B | $-2.28B | $-25.82B | $3.62B | $3.52B |
| Gross Margin % | -28.7% | -26.5% | -23.0% | -238.8% | 36.7% | 38.7% |
| Operating Expenses | $9.95B | $8.93B | $7.99B | $8.82B | $8.97B | $7.58B |
| Research & Development | $415.00M | $359.00M | $359.00M | $385.00M | $331.00M | $300.00M |
| Selling General & Admin | $1.20B | $1.02B | $876.00M | $1.16B | $1.33B | $924.00M |
| Other Income/Expense | $285.00M | $298.00M | $302.00M | $299.00M | $1.02B | $-63.00M |
| Income Before Tax | $2.52B | $2.39B | $2.25B | $2.29B | $1.89B | $1.45B |
| Income Tax Expense | $344.00M | $388.00M | $283.00M | $395.00M | $198.00M | $125.00M |
| Net Income | $2.16B | $2.03B | $1.98B | $1.90B | $1.85B | $1.27B |
| Net Margin % | 17.7% | 18.4% | 19.9% | 17.6% | 18.8% | 13.9% |
| Basic EPS | 2.04 | 1.91 | 1.85 | 1.76 | 1.71 | 1.16 |
| Diluted EPS | 2.02 | 1.89 | 1.83 | 1.75 | 1.70 | 1.15 |
| Breakdown | Q3 2025 (Sep 30, 2025) |
Q2 2025 (Jun 30, 2025) |
Q1 2025 (Mar 31, 2025) |
Q4 2024 (Dec 31, 2024) |
Q3 2024 (Sep 30, 2024) |
Q2 2024 (Jun 30, 2024) |
|---|---|---|---|---|---|---|
| Accounts Receivable | $10.67B | $10.51B | $9.65B | $9.33B | $8.94B | $8.37B |
| Inventory | $11.67B | $11.30B | $10.50B | $9.76B | $9.72B | $9.47B |
| Other Current Assets | $1.12B | $1.07B | $1.07B | $962.00M | $1.16B | $1.21B |
| Total Current Assets | $40.07B | $37.80B | $37.58B | $37.63B | $38.65B | $37.35B |
| Goodwill | $9.04B | $9.01B | $8.70B | $8.54B | $8.75B | $8.86B |
| Intangible Assets | $4.28B | $4.34B | $4.28B | $4.26B | $4.37B | $4.39B |
| Long-term Investments | $38.16B | $37.89B | $38.01B | $37.74B | $39.51B | $38.13B |
| Other Non-current Assets | $15.56B | $15.00B | $14.45B | $13.91B | $13.84B | $13.40B |
| Total Assets | $128.24B | $125.26B | $124.12B | $123.14B | $126.70B | $123.19B |
| Accounts Payable | $9.48B | $9.49B | $8.62B | $7.91B | $7.83B | $7.71B |
| Short-term Debt | $2.07B | $1.89B | $2.08B | $2.04B | $1.68B | $1.70B |
| Deferred Revenue | $9.85B | $9.74B | $9.62B | $9.35B | $9.05B | $8.67B |
| Other Current Liabilities | $4.79B | $4.39B | $4.21B | $4.92B | $4.99B | $4.51B |
| Total Current Liabilities | $37.20B | $36.47B | $34.94B | $34.39B | $34.09B | $32.75B |
| Long-term Debt | $18.77B | $17.00B | $17.49B | $17.23B | $18.24B | $17.97B |
| Other Non-current Liabilities | $7.00B | $6.50B | $6.54B | $6.38B | $6.65B | $6.53B |
| Total Liabilities | $109.22B | $105.91B | $104.65B | $103.58B | $107.59B | $104.35B |
| Common Stock | $15.00M | $15.00M | $15.00M | $15.00M | $15.00M | $15.00M |
| Retained Earnings | $85.50B | $83.73B | $82.08B | $80.49B | $78.89B | $77.35B |
| Total Stockholders Equity | $18.81B | $19.14B | $19.25B | $19.34B | $18.87B | $18.60B |
| Total Liabilities & Equity | $128.24B | $125.26B | $124.12B | $123.14B | $126.70B | $123.19B |
| Breakdown | Q3 2025 (Sep 30, 2025) |
Q2 2025 (Jun 30, 2025) |
Q1 2025 (Mar 31, 2025) |
Q4 2024 (Dec 31, 2024) |
Q3 2024 (Sep 30, 2024) |
Q2 2024 (Jun 30, 2024) |
|---|---|---|---|---|---|---|
| Net Income | $2.16B | $2.03B | $1.98B | $1.90B | $4.66B | $2.81B |
| Change in Receivables | $1.27B | $1.16B | $326.00M | $326.00M | $750.00M | $48.00M |
| Change in Inventory | $1.79B | $1.39B | $724.00M | $112.00M | $1.42B | $1.20B |
| Change in Payables | $1.50B | $1.50B | $706.00M | $128.00M | $560.00M | $427.00M |
| Operating Cash Flow | $6.26B | $3.75B | $1.51B | $1.30B | $3.41B | $1.91B |
| Capital Expenditure | $842.00M | $535.00M | $208.00M | $267.00M | $765.00M | $499.00M |
| Acquisitions | $360.00M | $354.00M | $100.00M | $9.00M | $126.00M | - |
| Investing Cash Flow | $-1.46B | $-852.00M | $-317.00M | $321.00M | $-1.99B | $-3.48B |
| Stock Repurchased | $5.55B | $3.71B | $1.97B | $1.67B | $4.16B | $2.62B |
| Financing Cash Flow | $-5.86B | $-5.49B | $-2.28B | $-2.17B | $-4.55B | $-3.09B |
| Net Change in Cash | $-868.00M | $-2.40B | $-1.01B | $-692.00M | $-3.18B | $-4.81B |
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing
Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
| Description | Sep 30, 2025 | Sep 30, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Total Revenue | $12.18B | $9.84B | $33.14B | $27.89B |
| Operating Expenses | $9.95B | $8.97B | $26.87B | $24.53B |
| Research & Development | $415.00M | $331.00M | $1.13B | $901.00M |
| Selling General & Admin | $1.20B | $1.33B | $3.09B | $3.28B |
| Other Income/Expense | $285.00M | $1.02B | $885.00M | $1.97B |
| Income Before Tax | $2.52B | $1.89B | $7.15B | $5.33B |
| Income Tax Expense | $344.00M | $198.00M | $1.01B | $567.00M |
| Net Income | $2.16B | $1.85B | $6.16B | $4.66B |
| Basic EPS | 2.04 | 1.71 | 5.79 | 4.28 |
| Diluted EPS | 2.02 | 1.70 | 5.75 | 4.24 |
Condensed Consolidated Balance Sheets
| Description | Sep 30, 2025 | Dec 31, 2024 |
|---|---|---|
| Accounts Receivable | $10.67B | $9.33B |
| Inventory | $11.67B | $9.76B |
| Other Current Assets | $1.12B | $962.00M |
| Total Current Assets | $40.07B | $37.63B |
| Goodwill | $9.04B | $8.54B |
| Intangible Assets | $4.28B | $4.26B |
| Long-term Investments | $38.16B | $37.74B |
| Other Non-current Assets | $15.56B | $13.91B |
| Total Assets | $128.24B | $123.14B |
| Accounts Payable | $9.48B | $7.91B |
| Short-term Debt | $2.07B | $2.04B |
| Deferred Revenue | $9.85B | $9.35B |
| Other Current Liabilities | $4.79B | $4.92B |
| Total Current Liabilities | $37.20B | $34.39B |
| Long-term Debt | $18.77B | $17.23B |
| Other Non-current Liabilities | $7.00B | $6.38B |
| Total Liabilities | $109.22B | $103.58B |
| Common Stock | $15.00M | $15.00M |
| Retained Earnings | $85.50B | $80.49B |
| Total Stockholders Equity | $18.81B | $19.34B |
| Total Liabilities & Equity | $128.24B | $123.14B |
Condensed Consolidated Statements of Cash Flows
| Description | Sep 30, 2025 | Sep 30, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Net Income | $2.16B | $1.85B | $6.16B | $4.66B |
| Change in Receivables | - | - | $1.27B | $750.00M |
| Change in Inventory | - | - | $1.79B | $1.42B |
| Change in Payables | - | - | $1.50B | $560.00M |
| Operating Cash Flow | - | - | $6.26B | $3.41B |
| Capital Expenditure | - | - | $842.00M | $765.00M |
| Acquisitions | - | - | $360.00M | $126.00M |
| Investing Cash Flow | - | - | $-1.46B | $-1.99B |
| Stock Repurchased | - | - | $5.55B | $4.16B |
| Financing Cash Flow | - | - | $-5.86B | $-4.55B |
| Net Change in Cash | - | - | $-868.00M | $-3.18B |
All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-Q filings.
Quarterly data represents single quarter results (Q1-Q4). Some items may show year-to-date values if quarterly breakdown is unavailable.